RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+11.82%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$1.05B
AUM Growth
+$1.05B
(+8.4%)
Cap. Flow
+$5.19M
Cap. Flow
% of AUM
0.5%
Top 10 Holdings %
Top 10 Hldgs %
49.49%
Holding
61
New
15
Increased
22
Reduced
15
Closed
7
Top Buys
| 1 |
SPDR S&P Biotech ETF
XBI
|
$26.6M |
| 2 |
Molina Healthcare
MOH
|
$25.8M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$23.6M |
| 4 |
NVRO
NEVRO CORP.
NVRO
|
$19.8M |
| 5 |
ELGX
Endologix Inc
ELGX
|
$18.6M |
Top Sells
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
$51.7M |
| 2 |
Ironwood Pharmaceuticals
IRWD
|
$50.7M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$33.8M |
| 4 |
AGN
Allergan plc
AGN
|
$30.7M |
| 5 |
Penumbra
PEN
|
$24.1M |
Sector Composition
| 1 | Healthcare | 73.5% |
| 2 | Financials | 2.71% |
| 3 | Communication Services | 2.42% |
| 4 | Industrials | 0.75% |
| 5 | Consumer Staples | 0.61% |
